Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ferrosoferric Oxide | 5 | 2019 | 348 | 1.640 |
Why?
|
Portal Vein | 3 | 2024 | 435 | 0.980 |
Why?
|
Magnetic Resonance Imaging | 24 | 2024 | 36743 | 0.960 |
Why?
|
Tomography, X-Ray Computed | 28 | 2025 | 20760 | 0.890 |
Why?
|
Vascular Diseases | 4 | 2020 | 1162 | 0.860 |
Why?
|
Diagnostic Imaging | 11 | 2024 | 3533 | 0.840 |
Why?
|
Coronary Angiography | 10 | 2023 | 4541 | 0.770 |
Why?
|
Venous Thrombosis | 3 | 2020 | 1323 | 0.770 |
Why?
|
Societies, Medical | 9 | 2024 | 3968 | 0.760 |
Why?
|
Aorta | 6 | 2024 | 2045 | 0.740 |
Why?
|
Magnetic Resonance Angiography | 4 | 2023 | 1429 | 0.700 |
Why?
|
Contrast Media | 15 | 2019 | 5330 | 0.690 |
Why?
|
Vena Cava, Inferior | 2 | 2020 | 463 | 0.660 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.630 |
Why?
|
Pelvic Neoplasms | 2 | 2020 | 250 | 0.630 |
Why?
|
Abdominal Injuries | 1 | 2022 | 362 | 0.630 |
Why?
|
Aortic Aneurysm, Thoracic | 3 | 2022 | 707 | 0.620 |
Why?
|
Mitral Valve Stenosis | 1 | 2020 | 342 | 0.600 |
Why?
|
Intestinal Diseases | 2 | 2022 | 505 | 0.600 |
Why?
|
Ultrasonography, Doppler | 1 | 2020 | 463 | 0.600 |
Why?
|
Coronary Aneurysm | 2 | 2018 | 234 | 0.590 |
Why?
|
Image Enhancement | 3 | 2019 | 2880 | 0.580 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.580 |
Why?
|
Coronary Vessel Anomalies | 2 | 2018 | 308 | 0.580 |
Why?
|
Lymphatic Diseases | 3 | 2015 | 319 | 0.570 |
Why?
|
Aortic Aneurysm | 1 | 2022 | 649 | 0.570 |
Why?
|
Plaque, Atherosclerotic | 4 | 2024 | 1551 | 0.550 |
Why?
|
Veins | 1 | 2021 | 769 | 0.550 |
Why?
|
Evidence-Based Medicine | 5 | 2024 | 3706 | 0.550 |
Why?
|
Lymphoma | 3 | 2017 | 1898 | 0.520 |
Why?
|
Pelvis | 4 | 2020 | 736 | 0.520 |
Why?
|
Vascular Malformations | 1 | 2021 | 469 | 0.500 |
Why?
|
Abdominal Neoplasms | 1 | 2017 | 287 | 0.500 |
Why?
|
Radiotherapy, Conformal | 1 | 2018 | 549 | 0.490 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2024 | 1250 | 0.460 |
Why?
|
Heart Transplantation | 3 | 2024 | 3301 | 0.460 |
Why?
|
Urinary Reservoirs, Continent | 1 | 2014 | 29 | 0.460 |
Why?
|
Artifacts | 2 | 2022 | 1926 | 0.450 |
Why?
|
Urogenital Surgical Procedures | 1 | 2014 | 34 | 0.450 |
Why?
|
Urinary Diversion | 1 | 2014 | 134 | 0.430 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.430 |
Why?
|
Male Urogenital Diseases | 1 | 2013 | 48 | 0.430 |
Why?
|
Adipose Tissue | 2 | 2018 | 3329 | 0.430 |
Why?
|
Lymph Nodes | 6 | 2020 | 3474 | 0.420 |
Why?
|
Urogenital Neoplasms | 1 | 2014 | 130 | 0.410 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 806 | 0.410 |
Why?
|
Viscera | 1 | 2013 | 138 | 0.400 |
Why?
|
Infectious Mononucleosis | 1 | 2013 | 133 | 0.400 |
Why?
|
Coronary Artery Disease | 6 | 2025 | 6568 | 0.400 |
Why?
|
Mitral Valve | 1 | 2020 | 1475 | 0.390 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2017 | 539 | 0.390 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2015 | 3390 | 0.390 |
Why?
|
Kidney Function Tests | 1 | 2014 | 684 | 0.390 |
Why?
|
Digestive System Diseases | 1 | 2013 | 152 | 0.380 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2018 | 2815 | 0.370 |
Why?
|
Penile Neoplasms | 1 | 2012 | 158 | 0.360 |
Why?
|
Prostatic Neoplasms | 5 | 2020 | 11101 | 0.360 |
Why?
|
Mitral Valve Insufficiency | 1 | 2020 | 1415 | 0.360 |
Why?
|
Humans | 94 | 2025 | 768166 | 0.340 |
Why?
|
Radiology | 1 | 2024 | 2104 | 0.340 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.340 |
Why?
|
Thrombosis | 2 | 2021 | 2957 | 0.340 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2024 | 346 | 0.330 |
Why?
|
Pancreatic Neoplasms | 6 | 2022 | 5446 | 0.330 |
Why?
|
Androgen Antagonists | 1 | 2018 | 1412 | 0.330 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2258 | 0.330 |
Why?
|
Mass Screening | 1 | 2024 | 5458 | 0.300 |
Why?
|
Internship and Residency | 2 | 2022 | 5953 | 0.300 |
Why?
|
Inflammation | 5 | 2024 | 10873 | 0.300 |
Why?
|
Diffusion Tensor Imaging | 1 | 2018 | 2420 | 0.290 |
Why?
|
Urinary Bladder | 1 | 2014 | 1157 | 0.290 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1883 | 0.280 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4568 | 0.280 |
Why?
|
Heart Ventricles | 1 | 2019 | 3841 | 0.280 |
Why?
|
Health Personnel | 1 | 2020 | 3385 | 0.270 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2013 | 617 | 0.260 |
Why?
|
Prostate | 1 | 2014 | 1765 | 0.260 |
Why?
|
Male | 51 | 2025 | 364719 | 0.260 |
Why?
|
Coronary Vessels | 5 | 2025 | 3124 | 0.260 |
Why?
|
Heart | 3 | 2022 | 4446 | 0.260 |
Why?
|
Blood Coagulation Disorders | 2 | 2021 | 350 | 0.250 |
Why?
|
Collagen | 1 | 2014 | 2643 | 0.250 |
Why?
|
Coronary Stenosis | 2 | 2023 | 802 | 0.250 |
Why?
|
Middle Aged | 39 | 2025 | 223492 | 0.230 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1206 | 0.230 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6669 | 0.230 |
Why?
|
Tuberous Sclerosis | 3 | 2022 | 1042 | 0.220 |
Why?
|
Aged | 31 | 2025 | 171504 | 0.220 |
Why?
|
Algorithms | 2 | 2022 | 14164 | 0.210 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2023 | 42 | 0.210 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 106 | 0.210 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2914 | 0.210 |
Why?
|
Sensitivity and Specificity | 8 | 2019 | 14729 | 0.210 |
Why?
|
Diagnostic Errors | 2 | 2024 | 1281 | 0.200 |
Why?
|
Angiomyolipoma | 2 | 2015 | 189 | 0.200 |
Why?
|
Phlebography | 1 | 2023 | 326 | 0.200 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1304 | 0.190 |
Why?
|
Predictive Value of Tests | 15 | 2024 | 15454 | 0.190 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2019 | 139 | 0.190 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 659 | 0.190 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2022 | 137 | 0.190 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2025 | 238 | 0.180 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2257 | 0.180 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 13014 | 0.180 |
Why?
|
Carcinoma, Renal Cell | 2 | 2015 | 3187 | 0.180 |
Why?
|
Retrospective Studies | 23 | 2023 | 81762 | 0.180 |
Why?
|
Abdomen | 2 | 2019 | 1136 | 0.180 |
Why?
|
Aneurysm, False | 1 | 2023 | 263 | 0.180 |
Why?
|
Female | 41 | 2025 | 397192 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2018 | 1622 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.170 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2020 | 25 | 0.170 |
Why?
|
Diverticulum | 1 | 2021 | 137 | 0.170 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2012 | 2195 | 0.170 |
Why?
|
Kidney Neoplasms | 3 | 2015 | 4282 | 0.170 |
Why?
|
Adenocarcinoma | 2 | 2014 | 6395 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 2055 | 0.160 |
Why?
|
Epigastric Arteries | 2 | 2022 | 93 | 0.160 |
Why?
|
Kidney | 1 | 2014 | 7064 | 0.150 |
Why?
|
Quinolines | 1 | 2024 | 772 | 0.150 |
Why?
|
Echocardiography | 3 | 2023 | 5047 | 0.150 |
Why?
|
Nitroglycerin | 1 | 2019 | 332 | 0.150 |
Why?
|
Platelet Count | 1 | 2020 | 787 | 0.150 |
Why?
|
Aortic Diseases | 1 | 2024 | 741 | 0.150 |
Why?
|
Necrosis | 1 | 2022 | 1616 | 0.150 |
Why?
|
Extremities | 1 | 2023 | 870 | 0.140 |
Why?
|
Adult | 24 | 2024 | 223646 | 0.140 |
Why?
|
Vasculitis | 1 | 2021 | 525 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2024 | 1126 | 0.140 |
Why?
|
Atrial Appendage | 1 | 2021 | 285 | 0.140 |
Why?
|
Appendiceal Neoplasms | 1 | 2019 | 155 | 0.140 |
Why?
|
Ischemia | 2 | 2023 | 1900 | 0.140 |
Why?
|
Statistics as Topic | 2 | 2014 | 2357 | 0.140 |
Why?
|
Iopamidol | 2 | 2016 | 187 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 171 | 0.130 |
Why?
|
Arteries | 2 | 2024 | 1127 | 0.130 |
Why?
|
T-Lymphocyte Subsets | 1 | 2024 | 1815 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 841 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1030 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2019 | 20227 | 0.120 |
Why?
|
Hemoptysis | 1 | 2016 | 152 | 0.120 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2017 | 175 | 0.120 |
Why?
|
Incidental Findings | 2 | 2017 | 698 | 0.120 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2194 | 0.120 |
Why?
|
Vasodilation | 1 | 2019 | 967 | 0.120 |
Why?
|
alpha-Fetoproteins | 1 | 2015 | 229 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2021 | 1162 | 0.120 |
Why?
|
Upper Extremity | 2 | 2020 | 683 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 990 | 0.120 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2022 | 1456 | 0.120 |
Why?
|
Hospitals, General | 2 | 2016 | 809 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1443 | 0.120 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 220 | 0.120 |
Why?
|
Mammaplasty | 2 | 2022 | 1268 | 0.110 |
Why?
|
Preoperative Care | 2 | 2014 | 2258 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 406 | 0.110 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2017 | 282 | 0.110 |
Why?
|
Ganglia, Sympathetic | 1 | 2014 | 65 | 0.110 |
Why?
|
Metabolic Clearance Rate | 1 | 2014 | 363 | 0.110 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 515 | 0.110 |
Why?
|
Treatment Outcome | 9 | 2023 | 65371 | 0.110 |
Why?
|
Sarcoidosis | 1 | 2019 | 535 | 0.110 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2599 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5792 | 0.110 |
Why?
|
Practice Guidelines as Topic | 3 | 2020 | 7454 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 530 | 0.110 |
Why?
|
Lymphomatoid Granulomatosis | 1 | 2013 | 16 | 0.110 |
Why?
|
HIV Infections | 3 | 2024 | 17569 | 0.100 |
Why?
|
Abdominal Wall | 1 | 2014 | 166 | 0.100 |
Why?
|
Radiography | 1 | 2024 | 6983 | 0.100 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 55 | 0.100 |
Why?
|
Vascular System Injuries | 1 | 2016 | 248 | 0.100 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 312 | 0.100 |
Why?
|
Embolism, Air | 1 | 2012 | 110 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 744 | 0.100 |
Why?
|
Splenomegaly | 1 | 2013 | 192 | 0.100 |
Why?
|
Macrophages | 2 | 2024 | 5799 | 0.100 |
Why?
|
Appendicitis | 1 | 2019 | 690 | 0.100 |
Why?
|
Radiation Dosage | 2 | 2018 | 1967 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 599 | 0.100 |
Why?
|
Gallbladder Diseases | 1 | 2013 | 139 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 136 | 0.100 |
Why?
|
Diverticulitis, Colonic | 1 | 2013 | 139 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2012 | 2810 | 0.090 |
Why?
|
Health Expenditures | 1 | 2024 | 2389 | 0.090 |
Why?
|
Intracranial Embolism | 1 | 2012 | 188 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2014 | 315 | 0.090 |
Why?
|
Hepatitis | 1 | 2013 | 227 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2021 | 59629 | 0.090 |
Why?
|
Intermittent Claudication | 2 | 2023 | 305 | 0.090 |
Why?
|
Endovascular Procedures | 2 | 2022 | 2216 | 0.090 |
Why?
|
Radiopharmaceuticals | 3 | 2019 | 2735 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2013 | 557 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 849 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 701 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 828 | 0.090 |
Why?
|
Myocarditis | 1 | 2018 | 802 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 498 | 0.090 |
Why?
|
United States | 9 | 2024 | 73039 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2024 | 1104 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 714 | 0.090 |
Why?
|
Foramen Ovale, Patent | 1 | 2012 | 210 | 0.090 |
Why?
|
Tissue Distribution | 1 | 2014 | 2300 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2018 | 7951 | 0.080 |
Why?
|
Registries | 4 | 2018 | 8375 | 0.080 |
Why?
|
Vena Cava Filters | 1 | 2012 | 270 | 0.080 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 541 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 1309 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2726 | 0.080 |
Why?
|
Inpatients | 1 | 2021 | 2566 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3858 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10632 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 594 | 0.070 |
Why?
|
Adolescent | 9 | 2024 | 89169 | 0.070 |
Why?
|
Pancreas | 1 | 2015 | 1700 | 0.070 |
Why?
|
Gadolinium DTPA | 3 | 2016 | 823 | 0.070 |
Why?
|
Ultrasonography | 1 | 2021 | 6004 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1264 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2019 | 2056 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6498 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3433 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8542 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1757 | 0.060 |
Why?
|
Prospective Studies | 5 | 2023 | 54926 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2016 | 2100 | 0.060 |
Why?
|
Aorta, Thoracic | 2 | 2022 | 1110 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15662 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4788 | 0.060 |
Why?
|
Colonoscopy | 1 | 2013 | 1409 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11095 | 0.060 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11244 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
Radiography, Interventional | 1 | 2012 | 1131 | 0.060 |
Why?
|
Hemorrhage | 1 | 2016 | 3467 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2013 | 1183 | 0.060 |
Why?
|
Young Adult | 7 | 2016 | 60066 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4206 | 0.060 |
Why?
|
Pilot Projects | 2 | 2015 | 8741 | 0.060 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3620 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1061 | 0.060 |
Why?
|
Risk Factors | 5 | 2025 | 74944 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1523 | 0.050 |
Why?
|
Colombia | 1 | 2024 | 287 | 0.050 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2025 | 297 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11519 | 0.050 |
Why?
|
Societies, Scientific | 1 | 2023 | 223 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2021 | 5176 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2018 | 9015 | 0.050 |
Why?
|
Boston | 4 | 2016 | 9374 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2022 | 21206 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15832 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2541 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 2029 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2024 | 644 | 0.050 |
Why?
|
Subclavian Artery | 1 | 2021 | 138 | 0.040 |
Why?
|
Limb Salvage | 1 | 2023 | 488 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22291 | 0.040 |
Why?
|
Computer Simulation | 1 | 2014 | 6283 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3447 | 0.040 |
Why?
|
Tricuspid Valve | 1 | 2023 | 419 | 0.040 |
Why?
|
Infant | 2 | 2024 | 36535 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4916 | 0.040 |
Why?
|
Device Removal | 2 | 2016 | 643 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 60 | 0.040 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15948 | 0.040 |
Why?
|
Tablets | 1 | 2019 | 149 | 0.040 |
Why?
|
Prevalence | 4 | 2018 | 15869 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9495 | 0.040 |
Why?
|
Giant Cells | 1 | 2018 | 187 | 0.040 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2018 | 353 | 0.040 |
Why?
|
Ventricular Dysfunction | 1 | 2018 | 144 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1597 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2019 | 716 | 0.030 |
Why?
|
Reference Values | 2 | 2015 | 4938 | 0.030 |
Why?
|
Equipment Design | 2 | 2016 | 3522 | 0.030 |
Why?
|
Aerosols | 1 | 2019 | 634 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3628 | 0.030 |
Why?
|
Acute Disease | 2 | 2019 | 7243 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1597 | 0.030 |
Why?
|
Electrocardiography | 2 | 2019 | 6412 | 0.030 |
Why?
|
Aortography | 1 | 2016 | 422 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2021 | 1096 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1216 | 0.030 |
Why?
|
Iodine | 1 | 2016 | 285 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 281 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1861 | 0.030 |
Why?
|
Phenotype | 1 | 2012 | 16726 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2784 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3212 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2016 | 648 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8748 | 0.020 |
Why?
|
Gadolinium | 1 | 2016 | 964 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.020 |
Why?
|
Massachusetts | 2 | 2016 | 8890 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1377 | 0.020 |
Why?
|
Prognosis | 2 | 2024 | 30010 | 0.020 |
Why?
|
Causality | 1 | 2016 | 1254 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12465 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13586 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2873 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9384 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1498 | 0.020 |
Why?
|
Child | 4 | 2024 | 80917 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 923 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22371 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3683 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3436 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2125 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8509 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5315 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39348 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10101 | 0.010 |
Why?
|
Risk Assessment | 2 | 2018 | 24315 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2013 | 1679 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21538 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2011 | 1885 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40218 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2016 | 2298 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12840 | 0.010 |
Why?
|
Regression Analysis | 1 | 2012 | 6340 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10590 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 2907 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42669 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13671 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 13045 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14783 | 0.010 |
Why?
|
Liver | 1 | 2012 | 7577 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18412 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9419 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41754 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30238 | 0.000 |
Why?
|